Dental technology company Align Technology (NASDAQ:ALGN) announced better-than-expected revenue in Q4 CY2025, with sales up 5.3% year on year to $1.05 billion. The company expects next quarter’s revenue to be around $1.02 billion, close to analysts’ estimates. Its non-GAAP profit of $3.29 per share was 10.8% above analysts’ consensus estimates.
Dental technology company Align Technology (NASDAQ:ALGN) beat Wall Street’s revenue expectations in Q4 CY2025, with sales up 5.3% year on year to $1.05 billion. The company expects next quarter’s revenue to be around $1.02 billion, close to analysts’ estimates. Its non-GAAP profit of $3.29 per share was 10.8% above analysts’ consensus estimates.
Wall Street has issued downbeat forecasts for the stocks in this article.
These predictions are rare - financial institutions typically hesitate to say bad things about a company because it can jeopardize their other revenue-generating business lines like M&A advisory.
Generating cash is essential for any business, but not all cash-rich companies are great investments.
Some produce plenty of cash but fail to allocate it effectively, leading to missed opportunities.
Even if a company is profitable, it doesn’t always mean it’s a great investment.
Some struggle to maintain growth, face looming threats, or fail to reinvest wisely, limiting their future potential.
Over the last six months, Align Technology’s shares have sunk to $170.94, producing a disappointing 14.2% loss - a stark contrast to the S&P 500’s 11.3% gain. This might have investors contemplating their next move.
The S&P 500 (^GSPC) is home to the biggest and most well-known companies in the market, making it a go-to index for investors seeking stability.
But not all large-cap stocks are created equal - some are struggling with slowing growth, declining margins, or increased competition.
Personal health and wellness is one of the many secular tailwinds for healthcare companies. Those leading the charge have realized strong financial performance,
and over the past six months, the industry’s 13.5% return has closely followed the S&P 500.
Shares of dental technology company Align Technology (NASDAQ:ALGN)
jumped 6.2% in the afternoon session after the company announced the commercial availability of its Invisalign System with mandibular advancement in the Philippines. This new product was designed to correct specific jaw and teeth alignment issues in growing patients by simultaneously moving the lower jaw forward while straightening teeth, expanding the company's treatment portfolio. In other news, Align Technology also concluded an academic program roadshow across the Middle East to support digital orthodontic education. The stock's positive move came despite analysts at Evercore ISI lowering their price target on the shares to $170 from $220, though the firm did maintain its "Outperform" rating, suggesting investors focused more on the product news.
The landscape of dental care is undergoing an unprecedented transformation, moving beyond traditional methods into an era defined by precision, efficiency, and enhanced patient experience. At the heart of this revolution is digital dentistry, a broad spectrum of technological advancements that are fundamentally reshaping how oral health is diagnosed, treated, and managed. Leading this charge [...]
Let's delve into the developments on the US markets in the middle of the day on Tuesday. Below, you'll find the top gainers and losers within the S&P500 index during today's session.
As the Q3 earnings season wraps, let’s dig into this quarter’s best and worst performers in the dental equipment & technology industry, including Align Technology (NASDAQ:ALGN) and its peers.
A number of stocks jumped in the afternoon session after comments from a key Federal Reserve official bolstered hopes for an interest rate cut. New York Federal Reserve President John Williams stated he sees “room for a further adjustment” in the near term, sparking a significant market rally. Following his remarks, the probability of the central bank cutting rates at its December meeting jumped from 39% to over 73%, according to the CME FedWatch tool. This positive sentiment provided relief to markets amid concerns over high valuations, particularly in AI-related stocks.
